Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A. Klebanoff, … , Richard M. Siegel, Nicholas P. Restifo
Christopher A. Klebanoff, … , Richard M. Siegel, Nicholas P. Restifo
Published December 14, 2015
Citation Information: J Clin Invest. 2016;126(1):318-334. https://doi.org/10.1172/JCI81217.
View: Text | PDF
Research Article Immunology Oncology Article has an altmetric score of 28

Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy

  • Text
  • PDF
Abstract

Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell subsets results in superior persistence and antitumor immunity compared with ACT of populations containing more-differentiated effector memory and effector T cells. Despite a clear advantage of the less-differentiated populations, the majority of ACT trials utilize unfractionated T cell subsets. Here, we have challenged the notion that the mere presence of less-differentiated T cells in starting populations used to generate therapeutic T cells is sufficient to convey their desirable attributes. Using both mouse and human cells, we identified a T cell–T cell interaction whereby antigen-experienced subsets directly promote the phenotypic, functional, and metabolic differentiation of naive T cells. This process led to the loss of less-differentiated T cell subsets and resulted in impaired cellular persistence and tumor regression in mouse models following ACT. The T memory–induced conversion of naive T cells was mediated by a nonapoptotic Fas signal, resulting in Akt-driven cellular differentiation. Thus, induction of Fas signaling enhanced T cell differentiation and impaired antitumor immunity, while Fas signaling blockade preserved the antitumor efficacy of naive cells within mixed populations. These findings reveal that T cell subsets can synchronize their differentiation state in a process similar to quorum sensing in unicellular organisms and suggest that disruption of this quorum-like behavior among T cells has potential to enhance T cell–based immunotherapies.

Authors

Christopher A. Klebanoff, Christopher D. Scott, Anthony J. Leonardi, Tori N. Yamamoto, Anthony C. Cruz, Claudia Ouyang, Madhu Ramaswamy, Rahul Roychoudhuri, Yun Ji, Robert L. Eil, Madhusudhanan Sukumar, Joseph G. Crompton, Douglas C. Palmer, Zachary A. Borman, David Clever, Stacy K. Thomas, Shashankkumar Patel, Zhiya Yu, Pawel Muranski, Hui Liu, Ena Wang, Francesco M. Marincola, Alena Gros, Luca Gattinoni, Steven A. Rosenberg, Richard M. Siegel, Nicholas P. Restifo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2009 Total
Citations: 6 13 11 20 20 21 13 21 19 11 1 1 157
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (157)

Title and authors Publication Year
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy
Tzaban S, Stern O, Zisman E, Eisenberg G, Klein S, Frankenburg S, Lotem M
Frontiers in Immunology 2025
Novel Assignment of Gene Markers to Hematological and Immune Cells Based on Single-Cell Transcriptomics
Rosa ED, Alonso-Moreda N, Berral-González A, Sánchez-Luis E, González-Velasco O, Sánchez-Santos JM, Rivas JD
International Journal of Molecular Sciences 2025
Immunosenescence, Physical Exercise, and their Implications in Tumor Immunity and Immunotherapy
Yu X, Pei W, Li B, Sun S, Li W, Wu Q
International Journal of Biological Sciences 2025
Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis
Kulesh V, Peskov K, Helmlinger G, Bocharov G
Frontiers in Immunology 2025
MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis
Lv Y, Gao Y, Di W, Li Z, Shi Y, Hou T, Chen Y, Tian J, Xu M, Su W, Zhang M, Zhong J
Frontiers in Pharmacology 2025
CD95/Fas stoichiometry in future precision medicine.
Sica M, Roussel M, Legembre P
Cell death and differentiation 2025
FLT3L-induced virtual memory CD8 T cells engage the immune system against tumors.
Tu HF, Kung YJ, Lim L, Tao J, Hu MH, Cheng M, Xing D, Wu TC, Hung CF
Journal of biomedical science 2024
Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?
Aggeletopoulou I, Kalafateli M, Triantos C
International journal of molecular sciences 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit
Yi F, Cohen T, Zimmerman N, Dündar F, Zumbo P, Eltilib R, Brophy EJ, Arkin H, Feucht J, Gormally MV, Hackett CS, Kropp KN, Etxeberria I, Chandran SS, Park JH, Hsu KC, Sadelain M, Betel D, Klebanoff CA
2024
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Lo Presti V, Meringa A, Dunnebach E, van Velzen A, Moreira AV, Stam RW, Kotecha RS, Krippner-Heidenreich A, Heidenreich OT, Plantinga M, Cornel A, Sebestyen Z, Kuball J, van Til NP, Nierkens S
Journal for ImmunoTherapy of Cancer 2024
A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.
Xu J, Zhang W, Tong J, Liu C, Zhang Q, Cao L, Yu J, Zhou A, Ma J
Cancer Immunology, Immunotherapy 2024
Functionalized nanowires for miRNA-mediated therapeutic programming of naïve T cells.
Yee Mon KJ, Kim S, Dai Z, West JD, Zhu H, Jain R, Grimson A, Rudd BD, Singh A
Nature Nanotechnology 2024
Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment
Moraly J, Kondo T, Benzaoui M, DuSold J, Talluri S, Pouzolles MC, Chien C, Dardalhon V, Taylor N
Molecular Oncology 2024
Recent advancements in improving the efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy for hepatocellular carcinoma.
Ren T, Huang Y
Naunyn-Schmiedeberg's archives of pharmacology 2024
Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy
Li T, Guo S, Xu C, Zhang M, Lyu C, Xu H, Hou Z, Zhang M, Li X, Ren J, Liu C, Kong D, Hao D, Wang G
Journal for Immunotherapy of Cancer 2024
Biomaterial-Based Therapeutic Delivery of Immune Cells
Dravid AA, Singh A, García AJ
Advanced healthcare materials 2024
Rapidly Manufactured CAR-T with Conserved Cell Stemness and Distinctive Cytokine-Secreting Profile Shows Improved Anti-Tumor Efficacy
Tsao ST, Gu M, Xiong Q, Deng Y, Deng T, Fu C, Zhao Z, Zhang H, Liu C, Zhong X, Xiang F, Huang F, Wang H
Vaccines 2024
Memory stem CD8+T cells in HIV/Mtb mono- and co-infection: characteristics, implications, and clinical significance
Xiao J, Wang F, Yan H, Wang B, Su B, Lu X, Zhang T
Frontiers in Cellular and Infection Microbiology 2024
Senescent T Cells in Age-Related Diseases
Yu PJ, Zhou M, Liu Y, Du J
Aging and Disease 2024
Defining a TCF1-expressing progenitor allogeneic CD8 T cell subset in acute graft-versus-host disease
Solhwi Lee, Kunhee Lee, Hyeonjin Bae, Kyungmin Lee, Junghwa Lee, Junhui Ma, Ye Lee, Bo Lee, Woong-Yang Park, Se Im
Nature Communications 2023
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy
Sharma S, Woods M, Mehta NU, Sauer T, Parikh KS, Schmuck-Henneresse M, Zhang H, Mehta B, Brenner MK, Heslop HE, Rooney CM
Journal for ImmunoTherapy of Cancer 2023
IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation
Lee J, Lee K, Bae H, Lee K, Lee S, Ma J, Jo K, Kim I, Jee B, Kang M, Im SJ
Frontiers in immunology 2023
Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment
Wilson JJ, Wei J, Daamen AR, Sears JD, Bechtel E, Mayberry CL, Stafford GA, Bechtold L, Grammer AC, Lipsky PE, Roopenian DC, Chang CH
iScience 2023
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
Kapitza L, Ho N, Kerzel T, Frank AM, Thalheimer FB, Jamali A, Schaser T, Buchholz CJ, Hartmann J
Frontiers in immunology 2023
AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
Sakemura RL, Hefazi M, Cox MJ, Siegler EL, Sinha S, Hansen MJ, Stewart CM, Feigin JM, Roman CM, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, Fonkoua LA, Ruff MW, Forsman CL, Nevala WK, Boysen JC, Tschumper RC, Grand CL, Kuchimanchi KR, Mouritsen L, Foulks JM, Warner SL, Call TG, Parikh SA, Ding W, Kay NE, Kenderian SS
Cancer immunology research 2023
The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma
Xie Q, Hu C, Luo C
Journal of Cancer 2023
Cell Granularity Reflects Immune Cell Function and Enables Selection of Lymphocytes with Superior Attributes for Immunotherapy
Wu T, Tan JH, Sin W, Luah YH, Tan SY, Goh M, Birnbaum ME, Chen Q, Cheow LF
Advanced Science 2023
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies.
Ruella M, Korell F, Porazzi P, Maus MV
Nature reviews. Drug discovery 2023
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
Giardino Torchia ML, Moody G
Frontiers in immunology 2023
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes
Lee KP, Epstein B, Lake CM, Snow AL
2023
CAR T-cell manufacturing from naive/stem memory T-lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Francesco Manfredi, Eugenia Bezzecchi, Rita El Khoury, Rossana Norata, Francesca Sanvito, Maurilio Ponzoni, Beatrice Greco, Marta A Moresco, Matteo G. Carrabba, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci
Journal of Clinical Investigation 2022
Knowns and Unknowns about CAR-T Cell Dysfunction
A Titov, Y Kaminskiy, I Ganeeva, E Zmievskaya, A Valiullina, A Rakhmatullina, A Petukhov, R Miftakhova, A Rizvanov, E Bulatov
Cancers 2022
Interaction of Immune and Cancer Cells
M Klink, I Szulc-Kielbik
2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity
C Funk, S Wang, K Chen, A Waller, A Sharma, C Edgar, V Gupta, S Chandrakasan, J Zoine, A Fedanov, S Raikar, J Koff, C Flowers, S Coma, J Pachter, S Ravindranathan, H Spencer, M Shanmugam, E Waller
Blood 2022
Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, J Durgin, S Nunez-Cruz, J Patel, J Leferovich, M Pinzone, F Shen, K Cummins, G Plesa, V Cantu, S Reddy, F Bushman, S Gill, U ODoherty, R OConnor, M Milone
Nature Biomedical Engineering 2022
Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation
A Leonardi, C Argyropoulos, A Hamdy, R Proenca
Frontiers in immunology 2022
The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
Y Fujiwara, T Kato, F Hasegawa, M Sunahara, Y Tsurumaki
Pharmaceuticals (Basel, Switzerland) 2022
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes
P Shah, M Forget, M Frank, P Jiang, D Sakellariou-Thompson, L Federico, R Khairullah, C Neutzler, I Wistuba, C Chow, Y Long, J Fujimoto, S Lin, A Maitra, M Negrao, K Mitchell, A Weissferdt, A Vaporciyan, T Cascone, J Roth, J Zhang, B Sepesi, D Gibbons, J Heymach, C Haymaker, D McGrail, A Reuben, C Bernatchez
Journal for ImmunoTherapy of Cancer 2022
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Zhang C, He J, Liu L, Wang J, Wang S, Liu L, Ge J, Gao L, Gao L, Kong P, Liu Y, Liu J, Han Y, Zhang Y, Sun Z, Ye X, Yin W, Sersch M, Shen L, Cao WW, Zhang X
Blood Cancer Journal 2022
Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes
Knörck A, Schäfer G, Alansary D, Richter J, Thurner L, Hoth M, Schwarz EC
Frontiers in immunology 2022
HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity
Andrew Nguyen, Louisa Ho, Richard Hogg, Lan Chen, Scott R Walsh, Yonghong Wan
Journal of Clinical Investigation 2022
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
Caël B, Galaine J, Bardey I, Marton C, Fredon M, Biichle S, Poussard M, Godet Y, Angelot-Delettre F, Barisien C, Bésiers C, Adotevi O, Pouthier F, Garnache-Ottou F, Bôle-Richard E
Cancers 2022
Stem-like T cells and niches: Implications in human health and disease
Yi L, Yang L
Frontiers in immunology 2022
Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment
Frazzette N, Cruz AC, Wu X, Hammer JA, Lippincott-Schwartz J, Siegel RM, Sengupta P
Cells 2022
High-Intensity Aerobic Exercise Suppresses Cancer Growth by Regulating Skeletal Muscle-Derived Oncogenes and Tumor Suppressors
Jee H, Park E, Hur K, Kang M, Kim Y
Frontiers in Molecular Biosciences 2022
Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells
Tan GM, Poudel A, Ali Hosseini Rad SM, McLellan AD
Cancers 2022
AKT Isoforms in the Immune Response in Cancer.
Ahmad Z, Somanath PR
Current topics in microbiology and immunology 2022
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
Maldonado-Pérez N, Tristán-Manzano M, Justicia-Lirio P, Martínez-Planes E, Muñoz P, Pavlovic K, Cortijo-Gutiérrez M, Blanco-Benítez C, Castella M, Juan M, Wenes M, Romero P, Molina-Estévez FJ, Marañón C, Herrera C, Benabdellah K, Martin F
Frontiers in immunology 2022
Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors
Li F, Zhao S, Wei C, Hu Y, Xu T, Xin X, Zhu T, Shang L, Ke S, Zhou J, Xu X, Gao Y, Zhao A, Gao J
Frontiers in immunology 2022
Challenges of COPD Patients during the COVID-19 Pandemic
Sun SW, Qi C, Xiong XZ
Pathogens 2022
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
JT Huckaby, E Landoni, TM Jacobs, B Savoldo, G Dotti, SK Lai
Journal for ImmunoTherapy of Cancer 2021
Improving CAR T-Cell Persistence
V Pietrobon, LA Todd, A Goswami, O Stefanson, Z Yang, F Marincola
International journal of molecular sciences 2021
Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
AH M., JC Halpin, M Mollaei, SW Bell, N Hirankarn, AD McLellan
Cancers 2021
Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
SS Qin, AD Melucci, AC Chacon, PA Prieto
Cells 2021
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches
M Caforio, E de Billy, BD Angelis, S Iacovelli, C Quintarelli, V Paganelli, V Folgiero
Cancers 2021
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
V Hofschröer, K Najder, M Rugi, R Bouazzi, M Cozzolino, A Arcangeli, G Panyi, A Schwab
Frontiers in pharmacology 2021
A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy
H Ren, K Cao, M Wang
Frontiers in immunology 2021
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
I Vanmeerbeek, DM Borras, J Sprooten, O Bechter, S Tejpar, AD Garg
Genes and Immunity 2021
Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy
A Pasetto, YC Lu
Frontiers in immunology 2021
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
S Chandrasekaran, CR Funk, T Kleber, CM Paulos, M Shanmugam, EK Waller
Frontiers in immunology 2021
PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8+ T cells at the expense of central memory
JL Cannons, AV Villarino, SM Kapnick, S Preite, HY Shih, J Gomez-Rodriguez, Z Kaul, H Shibata, JM Reilley, B Huang, R Handon, IT McBain, S Gossa, T Wu, HC Su, DB McGavern, JJ OShea, PJ McGuire, G Uzel, PL Schwartzberg
Cell Reports 2021
CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence
DM Richards, C Merz, C Gieffers, A Krendyukov
Cancer management and research 2021
Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
G Flores-Mendoza, N Rodríguez-Rodríguez, RM Rubio, IK Madera-Salcedo, F Rosetti, JC Crispín
Frontiers in immunology 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells
C Marton, P Mercier-Letondal, R Loyon, O Adotévi, C Borg, J Galaine, Y Godet
Cancer Gene Therapy 2021
Exercise and the immune system: taking steps to improve responses to cancer immunotherapy
MP Gustafson, CM Wheatley-Guy, AC Rosenthal, DA Gastineau, E Katsanis, BD Johnson, RJ Simpson
Journal for ImmunoTherapy of Cancer 2021
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Z Yang, L Li, A Turkoz, P Chen, R Harari-Steinfeld, M Bobbin, O Stefanson, H Choi, V Pietrobon, B Alphson, A Goswami, V Balan, A Kearney, D Patel, J Yang, D Inel, V Vinod, A Cesano, B Wang, KH Roh, LS Qi, FM Marincola
Journal of Translational Medicine 2021
Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL
B Deng, J Pan, Z Liu, S Liu, Y Chen, X Qu, Y Zhang, Y Lin, Y Zhang, X Yu, Z Zhang, X Niu, R Luan, M Ma, X Li, T Liu, , H Niu, AH Chang, C Tong
Molecular Therapy — Methods & Clinical Development 2021
Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials
S Smirnov, A Petukhov, K Levchuk, S Kulemzin, A Staliarova, K Lepik, O Shuvalov, A Zaritskey, A Daks, O Fedorova
Frontiers in immunology 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
W Gong, L Wang, S Stock, M Ni, M Schubert, B Neuber, C Kleist, A Hückelhoven-Krauss, D Wu, C Müller-Tidow, A Schmitt, H Shiku, M Schmitt, L Sellner
Cells 2021
LFA-1 in T cell priming, differentiation, and effector functions
Gerard A, Cope AP, Kemper C, Alon R, Köchl R
Trends in Immunology 2021
Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, Silvio Manfredo-Vieira, Selene Nunez-Cruz, Erik F. Williams, Charles-Antoine Assenmacher, Enrico Radaelli, Sangwook Oh, Baomei Wang, Christoph T. Ellebrecht, Joseph A. Fraietta, Michael C. Miloneǂ, Aimee S. Payne
Journal of Clinical Investigation 2020
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells
CM Mousset, W Hobo, A de Ligt, S Baardman, NP Schaap, JH Jansen, AB van der Waart, H Dolstra
Cancer Immunology, Immunotherapy 2020
Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-γ and TNF-⍺
M Haque, F Lei, X Xiong, Y Ren, A Kumar, JK Das, X Ren, D Fang, P de Figueiredo, JM Yang, J Song
iScience 2020
Group O plasma as a media supplement for CAR‐T cells and other adoptive T‐cell therapies
RC Nelson, V Fellowes, P Jin, H Liu, SL Highfill, J Ren, J Szymanski, WA Flegel, DF Stroncek
Transfusion 2020
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
E Chruściel, Z Urban-Wójciuk, Ł Arcimowicz, M Kurkowiak, J Kowalski, M Gliwiński, T Marjański, W Rzyman, W Biernat, R Dziadziuszko, C Montesano, R Bernardini, N Marek-Trzonkowska
Cancers 2020
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
LD Galva, L Cai, Y Shao, Y He
Journal of genetics and genomics = Yi chuan xue bao 2020
Development of CAR-T cell therapy for B-ALL using a point-of-care approach
L de Macedo Abdo, LR Barros, MS Viegas, LV Marques, P de Sousa Ferreira, L Chicaybam, MH Bonamino
OncoImmunology 2020
Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer
E Lafont
Cancers 2020
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
A Gavriil, M Barisa, E Halliwell, J Anderson
Cancers 2020
Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death
SS Ghare, PM Chilton, AV Rao, S Joshi-Barve, P Peyrani, AR Vega, CJ McClain, K Bryant, RL Cook, M Freiberg, S Barve
Journal of acquired immune deficiency syndromes (1999) 2020
Memory T cells: strategies for optimizing tumor immunotherapy
Q Liu, Z Sun, L Chen
Protein & Cell 2020
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
T Mika, S Ladigan-Badura, A Maghnouj, B Mustafa, S Klein-Scory, A Baraniskin, S Döhring, I Fuchs, S Ehl, SA Hahn, R Schroers
Frontiers in Oncology 2020
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 + T cells
CJ Dwyer, DC Arhontoulis, GO Rivera, HM Knochelmann, AS Smith, MM Wyatt, MP Rubinstein, C Atkinson, JE Thaxton, DM Neskey, CM Paulos
European Journal of Immunology 2020
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
SJ Im, SJ Ha
Immune Network 2020
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy
M Feist, Z Zhu, E Dai, C Ma, Z Liu, E Giehl, R Ravindranathan, SJ Kowalsky, N Obermajer, US Kammula, AJ Lee, MT Lotze, ZS Guo, DL Bartlett
Cancer Gene Therapy 2020
Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19
AJ Leonardi, RB Proenca
Frontiers in immunology 2020
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
S Arcangeli, L Falcone, B Camisa, FD Girardi, M Biondi, F Giglio, F Ciceri, C Bonini, A Bondanza, M Casucci
Frontiers in immunology 2020
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
ME Maccari, S Fuchs, P Kury, G Andrieux, S Völkl, B Bengsch, MR Lorenz, M Heeg, J Rohr, S Jägle, CN Castro, M Groß, U Warthorst, C König, I Fuchs, C Speckmann, J Thalhammer, FG Kapp, MG Seidel, G Dückers, S Schönberger, C Schütz, M Führer, R Kobbe, D Holzinger, C Klemann, P Smisek, S Owens, G Horneff, R Kolb, N Naumann-Bartsch, M Miano, J Staniek, M Rizzi, T Kalina, P Schneider, A Erxleben, R Backofen, A Ekici, CM Niemeyer, K Warnatz, B Grimbacher, H Eibel, A Mackensen, AP Frei, K Schwarz, M Boerries, S Ehl, A Rensing-Ehl
Journal of Experimental Medicine 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
M Kroemer, C Turco, L Spehner, J Viot, I Idirène, A Bouard, E Renaude, M Deschamps, Y Godet, O Adotévi, S Limat, B Heyd, M Jary, R Loyon, C Borg
Journal for ImmunoTherapy of Cancer 2020
Modes of Communication between T Cells and Relevance for Immune Responses
L Uhl, A Gérard
International journal of molecular sciences 2020
Additional possibilities of chimeric antigen receptor T-cells in B-cell lymphoma: combination therapy
Y Yang, J Zhou, C Cao, P Cai, X Wang, C Chang, J Wang, Q Zhang
Translational cancer research 2020
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Tori N. Yamamoto, Ping-Hsien Lee, Suman Kumar Vodnala, Devikala Gurusamy, Rigel Kishton, Zhiya Yu, Arash Eidizadeh, Robert Eil, Jessica Fioravanti, Luca Gattinoni, James N. Kochenderfer, Terry J Fry, Bulent Arman Aksoy, Jeffrey Hammerbacher, Anthony C Cruz, Richard Siegel, Nicholas P. Restifo, Christopher A. Klebanoff
Journal of Clinical Investigation 2019
Rethinking Communication in the Immune System: The Quorum Sensing Concept
L Antonioli, C Blandizzi, P Pacher, M Guilliams, G Haskó
Trends in Immunology 2019
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
CJ Dwyer, HM Knochelmann, AS Smith, MM Wyatt, GO Rivera, DC Arhontoulis, E Bartee, Z Li, MP Rubinstein, CM Paulos
Frontiers in immunology 2019
Generation and Immune Regulation of CD4+CD25−Foxp3+ T Cells in Chronic Obstructive Pulmonary Disease
JH Wu, M Zhou, Y Jin, ZJ Meng, XZ Xiong, SW Sun, SY Miao, HL Han, XN Tao
Frontiers in immunology 2019
Emerging Cellular Therapies for Cancer
S Guedan, M Ruella, CH June
Annual Review of Immunology 2019
TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity
Rossin, Miloro, Hueber
Cancers 2019
HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma
BW Dai, ZM Yang, P Deng, YR Chen, ZJ He, , S Zhang, HJ Wu, ZH Ren
Journal of Cancer 2019
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
SS Chandran, CA Klebanoff
Immunological Reviews 2019
Aging boosts antiviral CD8+T cell memory through improved engagement of diversified recall response determinants
B Davenport, J Eberlein, TT Nguyen, F Victorino, K Jhun, H Abuirqeba, V van der Heide, P Heeger, D Homann, GF Rall
PLoS pathogens 2019
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
S Stock, M Schmitt, L Sellner
International journal of molecular sciences 2019
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells
W Gong, JM Hoffmann, S Stock, L Wang, Y Liu, ML Schubert, B Neuber, A Hückelhoven-Krauss, U Gern, A Schmitt, C Müller-Tidow, H Shiku, M Schmitt, L Sellner
Cancer Immunology, Immunotherapy 2019
Developing neoantigen-targeted T cell–based treatments for solid tumors
TN Yamamoto, RJ Kishton, NP Restifo
Nature Medicine 2019
Cell-Based IL-15:IL-15Rα Secreting Vaccine as an Effective Therapy for CT26 Colon Cancer in Mice
Van Anh Do Thi, Hyung Min Jeon, Sang Min Park, Hayyoung Lee, Young Sang Kim
Molecules and Cells 2019
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
S Ghassemi, S Nunez-Cruz, RS O'Connor, JA Fraietta, PR Patel, J Scholler, DM Barrett, SM Lundh, MM Davis, F Bedoya, C Zhang, J Leferovich, SF Lacey, BL Levine, SA Grupp, CH June, JJ Melenhorst, MC Milone
Cancer immunology research 2018
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists
CT Petersen, M Hassan, AB Morris, J Jeffery, K Lee, N Jagirdar, AD Staton, SS Raikar, HT Spencer, T Sulchek, CR Flowers, EK Waller
Blood Advances 2018
Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model
A Contreras, MV Beems, AJ Tatar, S Sen, P Srinand, M Suresh, TK Luther, CS Cho
Journal for ImmunoTherapy of Cancer 2018
Epigenetic control of CD8+ T cell differentiation
AN Henning, R Roychoudhuri, NP Restifo
Nature Reviews Immunology 2018
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
HM Knochelmann, AS Smith, CJ Dwyer, MM Wyatt, S Mehrotra, CM Paulos
Frontiers in immunology 2018
Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
C Tomuleasa, S Fuji, C Berce, A Onaciu, S Chira, B Petrushev, WT Micu, V Moisoiu, C Osan, C Constantinescu, S Pasca, A Jurj, L Pop, I Berindan-Neagoe, D Dima, S Kitano
Frontiers in immunology 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
PA Ascierto, J Brugarolas, L Buonaguro, LH Butterfield, D Carbone, B Daniele, R Ferris, BA Fox, J Galon, C Gridelli, HL Kaufman, CA Klebanoff, I Melero, P Nathan, CM Paulos, M Ruella, R Sullivan, H Zarour, I Puzanov
Journal for ImmunoTherapy of Cancer 2018
Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
F Yi, N Frazzette, AC Cruz, CA Klebanoff, RM Siegel
Trends in Molecular Medicine 2018
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma:
KC Foley, MI Nishimura, TV Moore
Melanoma Research 2018
Silencing stemness in T cell differentiation
AN Henning, CA Klebanoff, NP Restifo
Science 2018
Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium
AR Medvec, C Ecker, H Kong, EA Winters, J Glover, A Varela-Rohena, JL Riley
Molecular Therapy — Methods & Clinical Development 2018
A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients
R Khouri, G Silva-Santos, T Dierckx, SM Menezes, D Decanine, K Theys, AC Silva, L Farré, A Bittencourt, M Mangino, M Roederer, AM Vandamme, JV Weyenbergh
OncoImmunology 2018
Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies
In-Young Jung, Jungmin Lee
Molecules and Cells 2018
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8 + T cells for adoptive immunotherapy
CM Mousset, W Hobo, Y Ji, H Fredrix, VD Giorgi, RD Allison, MG Kester, JH Falkenburg, NP Schaap, JH Jansen, L Gattinoni, H Dolstra, AB van der Waart
OncoImmunology 2018
Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation
MF Krummel, JN Mahale, LF Uhl, EA Hardison, AM Mujal, JM Mazet, RJ Weber, ZJ Gartner, A Gérard
Proceedings of the National Academy of Sciences 2018
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
KB Long, RM Young, AC Boesteanu, MM Davis, JJ Melenhorst, SF Lacey, DA DeGaramo, BL Levine, JA Fraietta
Frontiers in immunology 2018
Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells
B Omer, PA Castillo, H Tashiro, T Shum, MT Huynh, M Cardenas, M Tanaka, A Lewis, T Sauer, R Parihar, N Lapteva, M Schmueck-Henneresse, M Mukherjee, S Gottschalk, CM Rooney
Frontiers in Medicine 2018
Atypical Human Effector/Memory CD4+ T Cells With a Naive-Like Phenotype
N Caccamo, SA Joosten, TH Ottenhoff, F Dieli
Frontiers in immunology 2018
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
LL Yan, BN Liu
OncoTargets and therapy 2018
Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.
Aresvik DM, Øverland T, Lima K, Pettersen RD, Abrahamsen TG
Journal of Clinical Immunology 2018
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
J Zhu, PF Petit, BJ den Eynde
Cancer Immunology, Immunotherapy 2018
Transient stimulation expands superior antitumor T cells for adoptive therapy
Yuki Kagoya, Munehide Nakatsugawa, Toshiki Ochi, Yuchen Cen, Tingxi Guo, Mark Anczurowski, Kayoko Saso, Marcus Butler, Naoto Hirano
JCI Insight 2017
Th17 cells are refractory to senescence retaining robust antitumor activity after long-term ex vivo expansion
Jacob Bowers, Michelle H. Nelson, Kinga Majchrzak, Stefanie Bailey, Barbel Rohrer, Andrew Kaiser, Carl Atkinson, Luca Gattinoni, Chrystal Paulos
JCI Insight 2017
Inhibition of AKT-signaling uncouples T-cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher Klebanoff, Joseph G. Crompton, Anthony Leonardi, Tori Yamamoto, Smita Chandran, Robert Eil, Madhusudhanan Sukumar, Suman Kumar Vodnala, Jinhui Hu, Yun Ji, David Clever, Mary Black, Devikala Gurusamy, Michael Kruhlak, Ping Jin, David Stroncek, Luca Gattinoni, Steven A. Feldman, Nicholas Restifo
JCI Insight 2017
Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
A Ramadan, B Griesenauer, D Adom, R Kapur, H Hanenberg, C Liu, MH Kaplan, S Paczesny
Journal of Experimental Medicine 2017
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, DM Woods, AL Sodré, M Hansen, Y Meirow, M Sade-Feldman, A Burra, SS Kwek, C Flament, M Messaoudene, CP Duong, L Chen, BS Kwon, AC Anderson, VK Kuchroo, B Weide, F Aubin, C Borg, S Dalle, O Beatrix, M Ayyoub, B Balme, G Tomasic, AM di Giacomo, M Maio, D Schadendorf, I Melero, B Dréno, A Khammari, R Dummer, M Levesque, Y Koguchi, L Fong, M Lotem, M Baniyash, H Schmidt, IM Svane, G Kroemer, A Marabelle, S Michiels, A Cavalcanti, MJ Smyth, JS Weber, AM Eggermont, L Zitvogel
Nature Communications 2017
Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticles
SC Chuang, YC Chung, CD Yang
Parasite 2017
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
M Croft, RM Siegel
Nature Reviews Rheumatology 2017
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
C Fournier, F Martin, L Zitvogel, G Kroemer, L Galluzzi, L Apetoh
OncoImmunology 2017
PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, SR Bailey, LR Neal, JE Hammerbacher, CM Paulos
Frontiers in immunology 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
M Schmueck-Henneresse, B Omer, T Shum, H Tashiro, M Mamonkin, N Lapteva, S Sharma, L Rollins, G Dotti, P Reinke, HD Volk, CM Rooney
Journal of immunology (Baltimore, Md. : 1950) 2017
IL-21 augments rapamycin in expansion of alpha fetoprotein antigen specific stem-cell-like memory T cells in vitro
VT Jeza, X Li, J Chen, Z Liang, AO Aggrey, X Wu
The Pan African medical journal 2017
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
J Zhu, CG de Tenbossche, S Cané, D Colau, N Baren, C Lurquin, AM Schmitt-Verhulst, P Liljeström, C Uyttenhove, BJ van Eynde
Nature Communications 2017
Peripheral CD4+ naïve/memory ratio is an independent predictor of survival in non-small cell lung cancer
P Yang, J Ma, X Yang, W Li
Oncotarget 2017
Novel Immunotherapies for Multiple Myeloma
M DAgostino, M Boccadoro, EL Smith
Current Hematologic Malignancy Reports 2017
Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical Oncology
JG Crompton, N Klemen, US Kammula
Annals of Surgical Oncology 2017
Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity
S He, Y Liu, L Meng, H Sun, Y Wang, Y Ji, J Purushe, P Chen, C Li, J Madzo, JP Issa, J Soboloff, R Reshef, B Moore, L Gattinoni, Y Zhang
Nature Communications 2017
Multifaceted Role of BTLA in the Control of CD8 + T-cell Fate after Antigen Encounter
K Ritthipichai, CL Haymaker, M Martinez, A Aschenbrenner, X Yi, M Zhang, C Kale, LM Vence, J Roszik, Y Hailemichael, WW Overwijk, N Varadarajan, R Nurieva, LG Radvanyi, P Hwu, C Bernatchez
Clinical cancer research 2017
Modulation of CD8 + memory stem T cell activity and glycogen synthase kinase 3β inhibition enhances anti-tumoral immunity in gastric cancer
J Zhang, Y Zhao, Y Lv, P Cheng, W Chen, M Duan, Y Teng, T Wang, L Peng, F Mao, Y Liu, X Fu, P Yu, P Luo, W Zhang, Q Zou, Y Zhuang
OncoImmunology 2017
T memory stem cells in health and disease
L Gattinoni, DE Speiser, M Lichterfeld, C Bonini
Nature Medicine 2017
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
M Sabatino, J Hu, M Sommariva, S Gautam, V Fellowes, JD Hocker, S Dougherty, H Qin, CA Klebanoff, TJ Fry, RE Gress, JN Kochenderfer, DF Stroncek, Y Ji, L Gattinoni
Blood 2016
Role of memory T cell subsets for adoptive immunotherapy
DH Busch, SP Fräßle, D Sommermeyer, VR Buchholz, SR Riddell
Seminars in Immunology 2016
Regulatory circuits of T cell function in cancer
DE Speiser, PC Ho, G Verdeil
Nature Reviews Immunology 2016
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
HH van Acker, S Anguille, Y Willemen, JM van Bergh, ZN Berneman, E Lion, EL Smits, VF van Tendeloo
Journal of Hematology & Oncology 2016
Immunology: Channelling potassium to fight cancer
KG Chandy, RS Norton
Nature 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, B Rabinovich, H Huls, MA Forget, V Datar, P Kebriaei, DA Lee, RE Champlin, LJ Cooper
Proceedings of the National Academy of Sciences 2016
Driving gene-engineered T cell immunotherapy of cancer
LA Johnson, CH June
Cell Research 2016
Cell-Intrinsic Barriers of T Cell-Based Immunotherapy
HE Ghoneim, AE Zamora, PG Thomas, BA Youngblood
Trends in Molecular Medicine 2016
A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies
TL Lu, O Pugach, R Somerville, SA Rosenberg, JN Kochenderfer, M Better, SA Feldman
Human Gene Therapy Methods 2016
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction
AC Cruz, M Ramaswamy, C Ouyang, CA Klebanoff, P Sengupta, TN Yamamoto, F Meylan, SK Thomas, N Richoz, R Eil, S Price, R Casellas, VK Rao, J Lippincott-Schwartz, NP Restifo, RM Siegel
Nature Communications 2016
TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology
F Meylan, RM Siegel
Seminars in Immunopathology 2016
Selection bias: maintaining less differentiated T cells for adoptive immunotherapy
Yang Xu, Gianpietro Dotti
Journal of Clinical Investigation 2015
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 33 X users
Referenced in 19 patents
On 2 Facebook pages
Mentioned in 1 Google+ posts
342 readers on Mendeley
See more details